Provenance Wealth Advisors’s Biotricity, Inc. Common Stock BTCY Stock Holding History

Provenance Wealth Advisors’s Portfolio BTCY Stock Details BTCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-851	Closed	-$200	–	606
2024 Q3	$200	Hold	851	–	–	﹤0.01%	595
2024 Q2	$766	Buy	+851	New	+$980	﹤0.01%	471

Provenance Wealth Advisors's BTCY Position: Q4 2024 in Review

Provenance Wealth Advisors sold out of Biotricity, Inc. Common Stock (BTCY) in Q4 2024, closing a stake of 851 shares — an estimated $200 sold.

Provenance Wealth Advisors first reported a position in BTCY in Q2 2024 and held it in 2 quarters. The position peaked at $766 in Q2 2024. 0 funds tracked by Wall St. Rank hold BTCY as of Q4 2024.

Provenance Wealth Advisors reported no remaining Biotricity, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Provenance Wealth Advisors sold 851 Biotricity, Inc. Common Stock shares in Q4 2024, an estimated $200.
Provenance Wealth Advisors first reported a position in Biotricity, Inc. Common Stock in Q2 2024 and held it in 2 quarters.
Provenance Wealth Advisors's Biotricity, Inc. Common Stock position peaked at $766 in Q2 2024.
0 funds tracked by Wall St. Rank held Biotricity, Inc. Common Stock as of Q4 2024.

Based on Provenance Wealth Advisors's 13F filing for Q4 2024, filed 15 Aug 2025.